FDA Approved Postpartum Depression Medication To Cost Nearly $16,000

Zurzuvae was approved by the FDA in August and is the first medication cleared for postpartum depression that's taken in pill form.

The cost of a recently approved medication aimed specifically to treat postpartum depression has been revealed.

Zurzuvae was approved by the FDA in August and is the first medication cleared for postpartum depression that’s taken in pill form.

The new option will cost $15,900 per 14-day course, before insurance. Drugmaker Sage Therapeutics is currently talking with insurers about coverage plans. The company hopes that patients will be able to get the medicine with little to no co-pay regardless of financial means.

Zurzuvae is expected to become available next month. The current options to treat postpartum depression are Antidepressants.